Prinses Máxima Centrum Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2017
NCT03590171
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Princess Maxima Center for Pediatric Oncology in The Netherlands | Prinses Máxima Centrum (Co-Sponsor Netherlands)